Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT02188186

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02188186
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02188186. Randomized; triple masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2018-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
Intervention (Drug)
Initial triple combination
Intervention (Drug)
Conventional treatment
Lead sponsor
Seoul National University Bundang Hospital (class: other)

Record details

Record id
cardio:ct-nct02188186
Content hash
8f1a9879953393f075fcad8f6a8f1255f60d2dc4f1c6f4c8d33444bf7fcba83d